Pages Menu
Categories Menu

Resource Links


ACTG Website

ACTG Drug Interactions Database

Centers for Disease Control (list of AIDS Defining Conditions)

DAIDS Adverse Event reporting

DAIDS Clinical Site Monitoring (CSM) Training Announcement Training Announcement

DAIDS Frequently Asked Questions Regarding DAERS


DAIDS PAB PEP Template Sample Completed DAIDS PAB PEP Template

DAIDS Regulatory and Pharmacovigilence

DAIDS Regulatory Support Center

DAIDS Required Site SOP Samples Sample Templates

FSTRF Portal


NHLBI AIDS Funding Opportunities

PPD Monitor MACE Training

We’re currently seeking study participants to take part in REPRIEVE. Please contact us to learn more.

Latest Tweets

reprievetrial @reprievetrial
REPRIEVE Trial  @reprievetrialRT @NIAIDNews:#HIV affects people of all ages. In fact, nearly 1 in 4 people living with #HIV in the U.S. are 55 or older.… 
REPRIEVE Trial  @reprievetrialRT @jude_lavelle:It's National HIV/AIDS & Aging Awareness Day! Learn morea bout @reprievetrial's recent milestone:… 
REPRIEVE Trial  @reprievetrialWomen's hearts may respond differently to #HIV. The @reprievetrial is studying why this may be and what can be done… 
REPRIEVE Trial  @reprievetrialAging with #HIV? Learn about how you might be at an increased risk for heart disease and what is being done to prev… 
REPRIEVE Trial  @reprievetrialAn Orange County Register article about Dr. Judith Currier and the REPRIEVE Trial was featured in the Los Angeles D… 
REPRIEVE Trial  @reprievetrialThe @reprievetrial and Dr. Judith Currier were featured in the Los Angeles Daily News and 9 other So. Cal News Grou…